Home/Filings/4/0001055726-24-000023
4//SEC Filing

DANSEY ROGER D 4

Accession 0001055726-24-000023

CIK 0001055726other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 5:56 PM ET

Size

7.4 KB

Accession

0001055726-24-000023

Insider Transaction Report

Form 4
Period: 2024-05-13
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-13+1,0004,583 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-05-131,0000 total
    Common Stock (1,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 3,000 restricted stock units was as follows: 1,000 shares vested on May 13, 2022; 1,000 shares vested on May 13, 2023; and 1,000 shares vested on May 13, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.
  • [F2]Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

Entity typeother

Related Parties

1
  • filerCIK 0001741836

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:56 PM ET
Size
7.4 KB